Clinical Evidence: What 5mg Mounjaro Vs Wegovy Trials Reveal
What Is 5mg Mounjaro To Wegovy: Understanding Clinical Trial Evidence
When comparing what 5mg Mounjaro achieves versus Wegovy's proven results, the clinical evidence provides compelling insights for UK patients. Wegovy's comprehensive STEP trial programme demonstrates that patients taking the 2.4mg maintenance dose alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021). The STEP 1 trial specifically showed sustained results, with participants maintaining significant weight reduction compared to the 2.4% seen with placebo groups. This prescription-only medicine has been rigorously tested across multiple populations, providing robust evidence for its effectiveness in weight management.
The SELECT cardiovascular outcomes trial further reinforced Wegovy's clinical profile, demonstrating a 20% reduction in major cardiovascular events alongside weight loss benefits. When UK patients ask what 5mg Mounjaro compares to in Wegovy terms, they're essentially comparing different mechanisms - Mounjaro's dual GIP/GLP-1 approach versus Wegovy's focused GLP-1 receptor agonism. Both treatments are available through EverydayMeds' clinical assessment process, allowing your prescriber to determine which option aligns with your individual health profile and weight management objectives.
Wegovy Pricing Structure: What 5mg Mounjaro Costs Compare To UK Wegovy Options
Understanding what 5mg Mounjaro pricing compares to with Wegovy helps UK patients make informed financial decisions about their weight management journey. Wegovy's dose escalation begins with the 0.25mg starter pen at £79.99 (with code FIRST40 for new customers), progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the 2.4mg maintenance dose at £209.99. Our Progress Trio bundle (0.5mg, 1mg & 1.7mg) provides three months of step-up dosing for £369.99, ensuring uninterrupted treatment progression. Returning customers benefit from code DOSE25 at checkout, making ongoing treatment more accessible.
The Ultimate Stability Trio offers three 2.4mg maintenance pens for £649.99, providing consistent supply without multiple orders. When considering what 5mg Mounjaro costs versus Wegovy's maintenance phase, the investment in proven STEP trial outcomes becomes clear. Our bundles prioritise convenience and Reliable Supply rather than simple cost savings, ensuring patients maintain their treatment schedule without interruption. All prices include next-day cold-chain delivery from our GPhC-registered pharmacy (#9012878), maintaining medication integrity throughout the supply process.
STEP Trial Results: What 5mg Mounjaro To Wegovy Clinical Evidence Shows
The landmark STEP trials provide definitive answers about what 5mg Mounjaro compares to when evaluating Wegovy's clinical performance. STEP 1 enrolled 1,961 adults with obesity, demonstrating that patients taking Wegovy alongside reduced-calorie diet and increased physical activity achieved approximately 15% average weight loss at 68 weeks. STEP 3 combined Wegovy with intensive behavioural therapy, showing enhanced results of around 16% average weight reduction.
STEP 5's two-year data revealed sustained weight loss of approximately 15.2%, addressing concerns about long-term effectiveness. However, the trial extension also showed that patients regained approximately two-thirds of lost weight within one year of stopping treatment, emphasising that weight management requires ongoing commitment. These clinical results help contextualize what 5mg Mounjaro outcomes might compare to, though direct head-to-head comparisons aren't available due to different trial designs and populations.
How Wegovy Works: GLP-1 Mechanism Vs What 5mg Mounjaro Offers
Understanding what 5mg Mounjaro's dual mechanism compares to helps explain Wegovy's focused GLP-1 approach and its proven clinical outcomes. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone glucagon-like peptide-1, which your body produces after eating. This hormone signals satiety to your brain, reducing appetite and promoting feelings of fullness after smaller meals. Unlike Mounjaro's dual GIP/GLP-1 approach, Wegovy's targeted mechanism has been extensively studied through the STEP trial programme. The once-weekly FlexTouch pen delivers consistent medication levels, supporting appetite regulation throughout the week. Clinical studies suggest this mechanism may also reduce food cravings by acting on brain appetite centres, contributing to the sustained weight loss seen in STEP trials.
EverydayMeds Ordering Process: Accessing What 5mg Mounjaro To Wegovy Options
Determining what 5mg Mounjaro compares to with Wegovy begins with our streamlined three-minute online clinical assessment, designed to evaluate your suitability for either prescription-only medicine. Our qualified prescribers review your medical history, current medications, and weight management goals during the standard three working day review process, or within 24 hours with our express service. Once approved, your Wegovy prescription is prepared at our GPhC-registered pharmacy (#9012878) using cold-chain storage protocols to maintain medication integrity. Next-day delivery ensures you receive temperature-controlled medication in optimal condition, whether you're starting with the 0.25mg dose or continuing maintenance therapy. Our prescribers can help determine whether Wegovy's proven STEP trial results align with your individual circumstances, providing ongoing support throughout your weight management journey.
Storage Advantages: What 5mg Mounjaro To Wegovy Practical Differences
When comparing what 5mg Mounjaro storage requirements mean versus Wegovy's practical advantages, the temperature stability differences become significant for UK patients. Wegovy pens can remain at room temperature (below 30°C) for up to six weeks once removed from refrigerated storage, compared to Mounjaro's 21-day room temperature limit. This flexibility proves valuable for travel, work schedules, or situations where consistent refrigeration isn't available. The FlexTouch pen system requires refrigerated storage at 2-8°C before first use, but the extended room temperature tolerance provides practical advantages for busy lifestyles. Wegovy's dose escalation follows a structured 16-week progression from 0.25mg to 2.4mg maintenance, with each dose level specifically calibrated based on clinical trial protocols. This systematic approach, combined with superior storage flexibility, supports consistent treatment adherence throughout your weight management programme.
UK Weight Loss Results: What 5mg Mounjaro To Wegovy Outcomes Mean
Understanding what 5mg Mounjaro results translate to in Wegovy terms requires examining real-world UK patient outcomes alongside published clinical evidence. The STEP trials' ~15% average weight loss at 68 weeks provides a benchmark for evaluating Wegovy's effectiveness in clinical practice, though individual results vary based on adherence to reduced-calorie diet and increased physical activity. UK patients often report improved appetite control and reduced food cravings during the dose escalation phase, with many achieving meaningful weight loss before reaching the 2.4mg maintenance dose. The structured dose progression allows your body to adapt gradually, potentially minimising side effects whilst optimising therapeutic outcomes.
When considering what 5mg Mounjaro maintenance compares to, Wegovy's 2.4mg maintenance dose represents the culmination of 16 weeks of careful dose escalation, supported by comprehensive clinical trial evidence. The SELECT trial's cardiovascular benefits add another dimension to weight loss outcomes, particularly for UK patients with existing health conditions. Both treatments are available through EverydayMeds' clinical assessment process, allowing your prescriber to evaluate which option best supports your individual weight management goals and health circumstances.
Make Your Decision: What 5mg Mounjaro To Wegovy Choice Means
Choosing between what 5mg Mounjaro offers versus Wegovy's proven clinical profile requires careful consideration of your individual circumstances, treatment goals, and lifestyle factors. Our clinical assessment process evaluates your medical history, current medications, and weight management objectives to determine the most suitable prescription-only medicine for your needs. With Wegovy's comprehensive STEP trial evidence and Mounjaro's dual mechanism approach, both treatments offer distinct advantages depending on your situation. Use code FIRST40 as a new customer or DOSE25 for returning patients to access preferential pricing at checkout, ensuring cost-effective access to either treatment option. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment, with expert prescriber guidance available throughout the process to support your weight management journey with confidence and clinical oversight.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
